Dr. Saemundur “Sam” Oddsson is the Co-Founder and Chief Medical Officer of Sidekick Health, a fast-growing digital therapeutics (DTx) company transforming chronic disease management in more than a dozen countries. Trained in internal medicine and cardiology, Sam has a strong foundation in clinical research and digital health innovation. His early work evaluating digital interventions at Europe’s largest teaching hospital helped shape his mission: to build validated, patient-centered solutions that improve adherence, manage side effects, and deliver scalable real-world impact across therapeutic areas. 

Sidekick Health offers a uniquely broad portfolio of fully regulated, prescription-based digital health programs across oncology, cardiovascular and metabolic diseases, women’s health, and inflammatory conditions. The company collaborates with leading U.S. health insurers and half of the world’s top 10 life sciences companies. Its programs are prescribed by over 17,000 physicians in Germany alone, designed to improve outcomes, enhance clinical efficiency, and reduce the overall cost of care.